HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: Tolerability of Peginterferon Plus Ribavirin for Chronic Hepatitis C and HIV for Patients Receiving Antiretroviral Medication vs Not Receiving Antiretroviral Medication [Phase 3]
A Phase 3 trial evaluating tolerability of peginterferon plus ribavirin in chronic hepatitis C with and without antiretroviral therapy for H…
-
FDA approval · 2007-04-20FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie.
-
FDA approval · 2007-04-20FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie Inc. The approval authorizes changes to the pr…
-
CLINICAL_TRIALS trial_result · 2007-04-19Clinical Trial Update: Online HIV Prevention Vignette Evaluation [NA]
A completed clinical trial evaluating an online HIV prevention vignette.
-
CLINICAL_TRIALS trial_result · 2007-04-05Clinical Trial Update: A Comparison Study of Kaletra Soft-Gel Capsules and Kaletra Tablets in an African American Cohort [Phase 4]
Phase 4 trial comparing Kaletra soft-gel capsules with Kaletra tablets in African American participants with HIV infection and AIDS has comp…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2007-03-27Clinical Trial Update: Buprenorphine and Integrated HIV Care Evaluation [Phase 4]
Phase 4 clinical trial evaluating buprenorphine with integrated HIV care for individuals with opioid use disorder and HIV infection/AIDS; cu…
-
CLINICAL_TRIALS trial_result · 2007-03-23Clinical Trial Update: Botanical/Drug Interactions in HIV: Glucuronidation [Phase 1]
This is a Phase 1 clinical trial update from NCCIH investigating botanical-drug interactions focused on glucuronidation in HIV-seronegative …
-
FDA approval · 2007-03-22FDA Approved: REYATAZ — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
The FDA approved a supplemental application for Reyataz (atazanavir) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2007-03-19Clinical Trial Update: Botswana Tenofovir Oral HIV Prophylaxis Trial [Phase 2, Phase 3]
A Phase 2/3 trial evaluating oral tenofovir for HIV pre-exposure prophylaxis in Botswana has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-03-15Clinical Trial Update: Safety of Intradermal Versus Intramuscular Administration of HIV Lipopeptides in HIV Uninfected Adult Volunteers [Phase 1]
Phase 1 trial evaluating the safety of intradermal versus intramuscular administration of HIV lipopeptides in HIV-uninfected adults.
-
EMA safety_alert · 2007-03-05Public statement: Baraclude (entecavir): Occurrence of a resistant HIV variant in a patient co-infected with HIV and HBV
EMA public statement about the occurrence of a resistant HIV variant in a patient co-infected with HIV and hepatitis B while on Baraclude (e…
-
FDA approval · 2007-03-02FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Kaletra (lopinavir/ritonavir) from AbbVie, indicating an approval of a modification to the e…
-
FDA approval · 2007-03-02FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir/ritonavir) submitted by AbbVie.
-
CLINICAL_TRIALS research · 2007-03-01Clinical Trial Update: The Prevalence of Vitamin D Deficiency and Effects of Vitamin D Supplementation in HIV-1 Infected Patients [Phase 2]
This entry reports on a Phase 2 clinical trial evaluating how common vitamin D deficiency is among HIV-1 infected patients and the effects o…
-
CLINICAL_TRIALS trial_result · 2007-02-28Clinical Trial Update: Cellulose Sulfate (CS) Gel and HIV in Nigeria [Phase 3]
A Phase 3 trial of cellulose sulfate gel for HIV prevention in Nigeria was terminated. The study evaluated HIV infection prevention and othe…
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: ITV Extension Study [Phase 1, Phase 2]
This is an update on an HIV-focused ITV extension study spanning Phase 1 and Phase 2, which has completed.
-
CLINICAL_TRIALS trial_result · 2007-02-06Clinical Trial Update: Retinal Oxygen Reactivity in Patients Infected With Human Immunodeficiency Virus (HIV) [NA]
A completed clinical trial from the Medical University of Vienna examined retinal oxygen reactivity in patients with HIV infection.
-
CLINICAL_TRIALS trial_result · 2007-02-01Clinical Trial Update: Effect of Nutritional Intervention on the Lipid Profile of HIV-Positive Patients Who Start HAART: a Randomized Trial [NA]
This randomized trial evaluated the effect of a nutritional intervention on lipid profiles in HIV-positive patients starting HAART.
-
CLINICAL_TRIALS trial_result · 2007-02-01Clinical Trial Update: Assessment of Asymptomatic Heart Disease in Children With HIV [NA]
This entry notes a clinical trial evaluating asymptomatic heart disease in children with HIV. The current status is UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2007-01-18Clinical Trial Update: Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance [Phase 2]
Phase 2 trial evaluating the efficacy and tolerability of an antiretroviral bi-therapy in HIV infection with multidrug resistance; the study…
-
CLINICAL_TRIALS trial_result · 2007-01-12Clinical Trial Update: Rituximab in the Treatment of HIV Associated Multicentric Castleman Disease Dependent on Chemotherapy [Phase 2]
Phase 2 trial of rituximab in combination with chemotherapy for HIV-associated multicentric Castleman disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-01-11Clinical Trial Update: Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis [Phase 4]
A Phase 4 trial comparing three regimens for chemoprophylaxis of tuberculosis in patients co-infected with HIV has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-11Clinical Trial Update: BLADE: Comparison of Once Daily Lopinavir/Ritonavir to Lopinavir/Ritonavir BID Dosing in HIV-Infected Subjects
This clinical trial update reports on a study comparing once-daily lopinavir/ritonavir to the standard twice-daily regimen in HIV-infected s…
-
CLINICAL_TRIALS trial_result · 2007-01-09Clinical Trial Update: A Study of BufferGel in Women [Phase 1]
A Phase 1 clinical trial evaluating the safety of BufferGel in women for HIV infection; the study status is completed.
-
FDA approval · 2006-12-22FDA Approved: VIRACEPT — Supplemental Application (AGOURON)
FDA approved a supplemental application for Viracept (nelfinavir mesylate) submitted by Agouron.